National Dentex Labs (NDX) announced today that it is pleased to welcome Mr. David Waltzer as its new Chief Financial Officer. Mr. Waltzer will be responsible for all financial functions including accounting, audit, treasury, and corporate financial planning as well as acquisition integration activities.
“David brings more than 20 years of experience using a data-driven approach to drive profitability and sustainability across different industries. Specific to NDX’s interests, David has proven industry expertise in multi-unit health care services, manufacturing, distribution, and consumer products and services,” said NDX CEO, Tom Daulton.
During the early years of his career, Mr. Waltzer spent time in financial management in publically traded companies such as Lockheed Martin, XM Radio and Modus Link. Throughout the past 10 years, he has been a senior executive for three privately held companies; ClearChoice Dental Implant Centers, Pinnacle Dental and Caring Brands International.
A Florida native, Mr. Waltzer holds a Bachelors of Arts in Economics from the University of Maryland and a Master’s of Science in Business from the University of Baltimore.
About National Dentex Labs, LLC
National Dentex Labs, LLC (NDX) is a leading provider of dental prosthetics and restorative dentistry products. Dedicated to providing the highest quality products, exceptional service and latest dental restoration techniques and technologies, NDX offers crowns and bridges, dental implant restorations, guided full arch rehabilitation, appliances, and orthodontics, as well as headache and sleep therapy products. Headquartered in Palm Beach Gardens, Florida, NDX has a network of more than 30 labs across the US. GDC Holdings, Inc. is a private equity-sponsored entity and the owner of National Dentex Labs.
BIOLASE, Inc., a leader in medical devices, today announced that it expects to join the fight against the coronavirus (COVID-19) outbreak by teaming up with MEKICS Co. Ltd, an intensive care unit (ICU) equipment manufacturer, to supply MEKICS’s MTV-1000 ICU-grade portable ventilator through BIOLASE’s FDA-registered manufacturing facility in California. The MTV-1000 ventilator received FDA authorization for emergency use during the COVID-19 pandemic.
“In this time of global crisis, it is vital that companies come together to support the fight against COVID-19, leveraging every tool available, and that’s exactly what we intend to do,” said Todd Norbe, CEO of BIOLASE. “Without hesitation, we expect to pivot quickly and leverage our FDA-registered facility for the manufacturing and delivery of the MTV-1000 ventilator and have already received over $10 million in orders. We expect to continue to focus our efforts to quickly ramp up production, with the expectation to double the number of orders over the next few weeks.”
BIOLASE has received authorization to manufacture and supply the MTV-1000 ventilator under the FDA Emergency Use Authorization and an exemption from the State of California to operate, market and produce this critically needed product. BIOLASE expects to use its years of experience in manufacturing and distributing FDA-cleared medical equipment to help supply ventilators and support the global backorder on ventilators during the COVID-19 crisis.
The BIOLASE and MEKICS collaboration aims to bring the MTV-1000 to the United States for the first time. The MTV-1000 is a field-tested, ICU-level, portable ventilator that has pressure-control and an internal positive end-expiratory pressure (PEEP) feature, which is often required for COVID-19 patients.
“Collaborating with the team at BIOLASE, who have years of experience manufacturing, marketing and selling medical equipment in the United States, is a great opportunity for us to provide this much-needed product to the U.S. public,” said Jong Cheol Kim, CEO for MEKICS. “We are doing our very best to meet the demand of the U.S. market and believe it is an honor to help the American public in any way we can.”
MEKICS Co. Ltd. is a medical equipment company based at 21, Sangjiseok-gil, Paju-Si, Gyeonggi-do 10911, Korea with 20 years of experience in manufacturing various respiratory products, including ventilators.
About BIOLASE, Inc.
BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and surgical applications. BIOLASE's laser systems are designed to provide clinically superior, patient-friendly results for many types of common dental procedures compared to those achieved with traditional instruments. BIOLASE has sold over 41,000 laser systems to date in over 80 countries around the world.
Henry Schein, Inc. (Nasdaq: HSIC) announced today its latest virtual resource to help dental and medical practice owners navigate the COVID-19 pandemic. “Best Practices for Better Practices: A Henry Schein Wellness Symposium,” will launch on Thursday, April 9 at 10:00 a.m. EST. To register, click here.
As part of the Company’s continued offering of educational resources customers can rely on amid the outbreak, Henry Schein’s virtual symposium will present best practices on a broad range of topics from experts across a spectrum of specialties and backgrounds, including:
What’s Next With the Outbreak? – Bruce Lieberthal, Chief Innovation Officer, Henry Schein, with Dr. Amesh Adalja, Senior Scholar, Johns Hopkins University Center for Health Security;
Enhancing Team Morale and Maintaining Emotional Stability While Working Remotely – Barbara Fisenne, Vice President, Global Organizational Development, Henry Schein, with Dr. Kerry Sulkowicz, Managing Principal, Boswell Group LLC;
Maintaining Practice Financial Health – Natalie Westfall, Executive Director, Henry Schein Financial Services, with Mark Rosen, Partner, Rosen & Associates, LLP;
Patient Communications During and After COVID-19 – Andrea Gallimore, Product Marketing Manager, Henry Schein One, with Lois Banta, CEO, Banta Consulting;
Improving Patient Care with Telehealth Using Clinical Decision Support – Michael Casamassa, Vice President of Solutions and Planning, Henry Schein Medical, with Dr. Art Papier, CEO, VisualDx;
Maximizing Time During Office Closings – Scott Jackson, Senior Director, Ambulatory Surgery Center Segment, Henry Schein Medical, with Gayle Evans, President, Continuum Healthcare Consultants, and Sandra Sommerman, Senior Project Manager, Continuum Healthcare Consultants.
“Henry Schein has a long record of assisting our customers during difficult times,” said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. “This virtual symposium is another example of how our customers can rely on us to help health care practices manage through a challenging moment. We are committed to doing all we can to ensure that our customers emerge strong from the pandemic, and the best practices detailed in this symposium is a part of that effort.”
In addition to the symposium, Henry Schein provides a rich selection of practical information to help customers with the wide range of issues presented by the pandemic, which can be found on the Coronavirus (COVID-19) Resource Center. Customers can also find webinars on timely topics, and other helpful resources from Henry Schein and its partners on the Coronavirus (COVID-19) Education Center.
To learn more about what Henry Schein is doing to address this unprecedented situation and the actions the Company is taking to get more product into the hands of those who need it most – health care workers – please visit www.henryschein.com/COVID19update.
To register for the virtual symposium, visit https://henryscheindigital.com/covid-19-wellness-symposium.
About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 19,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional healthcare clinics, as well as other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.
A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 31 countries. The Company's sales from continuing operations reached $10.0 billion in 2019, and have grown at a compound annual rate of approximately 13 percent since Henry Schein became a public company in 1995.
The 30th annual Eastern Conference of Dental Laboratories (ECDL) has been scheduled for December 4-5 at Benton Convention Center in Winston-Salem, North Carolina.
The ECDL will make more information available soon on its website, eastern-conference.com.
Arlington Heights, Ill., April 6, 2020 – The Academy of Osseointegration (AO) is expanding its comprehensive live webinar series to provide members and dental professionals an essential portal through which to receive cutting-edge, evidence-based insights in implant dentistry, including COVID-19, and gain valuable CE credits.
Offered as a complimentary benefit for AO members, non-members can also register at a nominal fee for the following:
April 8 and 15: Healthcare Under COVID-19: Where we are now and Where we are Headed: A two-part course designed for dental professionals and their staff
Time: 8:00 pm ET
Register: April 8 session: https://bit.ly/2UKyXME
April 15: https://bit.ly/2JH6Mb4
This course will review the basic science of virology and COVID-19 in particular. Robert Lemke, DDS, MD will examine pandemics throughout history and how they can shed light on our present and future. He will also explore the impact of politics, social dynamics, geography, economics and ethics on the practice of oral surgery. Participants must register for each session separately.
April 9: “Why Digital?”
Time: Noon ET
There is a significant need of understanding how dentistry is changing. During this presentation, Christian Coachman, DDS, CDT will discuss the risks of not changing and the strategies to implement change. Participants should be able to identify the risk factors of not upgrading their practice to a digital platform, explain how dentistry is changing digitally, and list ways to upgrade to a digital environment.
April 15: “Peri-implant Diseases: Non-surgical Protocols”
Time: Noon ET
Presented by Marisa Roncati, RDH, DDS, this webinar is designed to provide participants with concrete clinical indications for practical nonsurgical treatment options. Upon completion, each clinician will be able to select the best therapeutic options for their own clinical reality, choose a comprehensive range of materials, techniques, protocol, and strategies, as well as discuss tips and tricks.
April 29: “Enhancing Peri-implant Esthetics Health and Patients’ Comfort With Autogeneous Soft Tissue Grafts”
Time: Noon ET
According to webinar presenter Lorenzo Tavelli, DDS, soft tissue management for dental implants has become crucial not only for enhancing esthetic outcomes of implant therapy, but also for improving implant health-related parameters. Although several techniques and materials have been investigated for soft tissue augmentation, autogenous grafts are still considered the treatment of choice.
Each of the above webinars are certified for 1.0 ADA-CERP credit hour and will be recorded. ADA CERP credit is available for 90 days following each live webinar or posted course. After 90 days, each webinar will be archived and no CE credit will be available.
To check out all of the Academy’s upcoming live webinar events, recent webinars and presentations, and its comprehensive video library of archived session recordings, please go to: https://osseo.org/learning-center/. All live and archived webinar presentations are complimentary as a member benefit to all active AO members. For non-members, there is a $50 fee for all live webinars up to 90 days following the live broadcast. The Video Library is not available to non-members.
For questions, please contact Kim Scroggs, the Academy’s Director of Education at firstname.lastname@example.org.
The AAE has published on its website a research article on COVID-19 and endodontic emergencies in Wuhan, China. The article is also being fast-track published on the Journal of Endodontics’ website, www.jendodon.com.
In late-2019, an outbreak of a new coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was detected in Wuhan, China. A great percentage of patients with this disease developed symptoms of dry cough, malaise and high fever. During this time, several patients requiring assessment and treatment of endodontic emergencies were directed to the School and Hospital of Stomatology at Wuhan University (WHUSS). Here, the characteristics of these patients were examined.
“Characteristics of Endodontic Emergencies during COVID-19 Outbreak in Wuhan” aimed to analyze the characteristics of endodontic emergency patients at WHUSS between February 22 and March 2, 2020, and is the first descriptive study that examines emergency dental patients at the epicenter of the COVID-19 outbreak. It also provides suggestions for endodontic practice and infection control strategies based on these novel observations.
The research was conducted by corresponding author Dr. Dan Zhao of State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) and Key Laboratory of Oral Biomedicine Ministry of Education, School and Hospital of Stomatology, Wuhan University.
The study concludes that endodontic emergencies consist of a much higher portion of dental emergencies in a COVID-19 high-risk area than normally. Reducing treatment time and exposure control are two ways to significantly reduce the risk of SARS-CoV-2 virus spreading during endodontic treatment.
“This latest research shows that vital pulp therapy can advantageously reduce treatment time, resulting in reduced risk of infection for vital pulp cases,” said AAE President Dr. Keith V. Krell. “It also demonstrates that the rubber dam, personal protective equipment and patient screening are of great importance during the COVID-19 outbreak in protecting clinicians.”
In addition, dentists should focus not only on the dental treatment, but also patients’ psychological status during public health emergencies.
The research comes on the heels of another AAE- and JOE-published article, “Coronavirus Disease 19 (COVID-19): Implications for Clinical Dental Care,” co-authored by University of Texas Health at San Antonio’s Endodontics Department Chair Dr. Ken M. Hargreaves.
“The AAE is swiftly disseminating the latest valuable research to dentistry and endodontics in the midst of this pandemic,” Dr. Krell said. “And it’s all easy to access on our website at aae.org/covid. We hope this latest information will further demonstrate the extreme importance of protecting endodontic specialists to help mitigate the spread of COVID-19.”
About the American Association of Endodontists: The AAE is headquartered in Chicago and represents more than 8,000 members worldwide. Endodontics is one of 10 dental specialties formally recognized by the American Dental Association. The AAE, founded in 1943, is dedicated to excellence in the art and science of endodontics and to the highest standard of patient care. The Association inspires its members to pursue professional advancement and personal fulfillment through education, research, advocacy, leadership, communication and service. For more information about the AAE, visit the Association’s website at aae.org. For more patient focused information, visit aae.org/patients.
Marion Manski, RDH, MS, former director of UMSOD’s Dental Hygiene Program, to
About University of Maryland School of Dentistry
With hospitals around the US experiencing shortages of surgical masks, ventilator valves, and more, various dental professionals with 3D printing capabilities have stepped up to contribute what help they can. Some have even shared their design files on social media for others to use on their own printers.
As Justin Marks, CDT, notes, anyone printing these products would be wise to take the time to evaluate their design, materials, and printing capabilities to ensure that the products will be of sufficient quality. Marks shares this article on that subject: 3D printing COVID-19: First Do No Harm.
For those dental professionals who feel comfortable moving forward, Inside Dental Technology has compiled some of the STL files that have been shared, all in one place. Inside Dental Technology has not verified the viability of these files or their status with the FDA or other regulatory bodies; this is not an endorsement of these designs, and anyone utilizing them should evaluate in full themselves.
Marks and his company, Arfona, shared files for a “remix” of the Prusa RC2 face shield:
Adam Nulty, BChD, shared files for ventilator quad splitters:
Nulty also shared files for N100 and N95 thermoform masks:
Additionally, Nulty shared files for Venturi valves for ventilators:
Paul Zhivago, DDS, shared links for two masks and a Venturi valve design:
Panthera Dental, meanwhile, posted STL files for various printing options for face shields on its website: https://pantheradental.com/covid-19/?fbclid=IwAR3I4y0aY_amrE6uRSKvOFCchGBosn0fv0yxx-cROZJsf4xUNBwfk_so_6Y.
Midwest Dental Arts also shared a DropBox link for its mask design: https://www.dropbox.com/sh/wwxp2e5g4a8dooj/AAB75qAdvSnffCJgU03MA5gxa?dl=0
DT will continue to update this page as the creators of these design files provide their permission.
Henry Schein has developed a CARES Act Landing page to help dental professionals access the help they need during the COVID-19 pandemic.
The page covers the Paycheck Protection Program, Economic Injury Disaster Loans (EIDL), the Federal CARES Act, and more.
With hospitals and emergency rooms overloaded, endodontist offices remain open for dental emergencies for those suffering from extreme tooth pain or other oral health related emergencies such as those that might require root canal treatment.
During the constantly evolving COVID-19 pandemic, hospitals and emergency rooms are experiencing extreme surges of patients seeking urgent care, leading to longer wait times for patients in need, shortages of medicine and equipment and clinician and staff overload.
To help reduce the number of ER and Urgent Care admitted patients, it’s important that patients contact an endodontist office first for all dental-related emergencies. If you are experiencing severe dental pain, dental infection symptoms (e.g. bleeding, swelling) or a dental infection-related fever, please contact your endodontist immediately or go to findmyendodontist.com to find a local endodontist.
Endodontists are tooth pain and root canal treatment specialists trained in diagnosing and treating tooth pain. They consider their role during this crisis to alleviate tooth pain, manage oral infections and reduce the need for patients to seek emergency dental care at ERs and Urgent Care facilities.
Please refer to the following for more information:
• CDC’s COVID-19 webpage - https://www.cdc.gov/coronavirus/2019-ncov/index.html
• AAE’s COVID-19 updates - https://www.aae.org/covid
About the American Association of Endodontists: The American Association of Endodontists (AAE) is headquartered in Chicago and represents more than 8,000 members worldwide. Endodontics is one of nine dental specialties formally recognized by the American Dental Association. The AAE, founded in 1943, is dedicated to excellence in the art and science of endodontics and to the highest standard of patient care. The Association inspires its members to pursue professional advancement and personal fulfillment through education, research, advocacy, leadership, communication and service. For more information about the AAE, visit the Association’s website at aae.org. For more patient focused information, visit aae.org/patients.